Personalized antibiotic dosing for ICU patients
Part of Infections clinical trials.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU or intermediate care unit of the General Surgery department
- You are receiving a beta-lactam antibiotic (like penicillin, cephalosporin, or carbapenem)
- You or a legal representative have signed an informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This trial tests a personalized approach to choosing antibiotics for people with severe lung infections in the ICU. It uses rapid tests and computer models to find the best treatment faster, which may help you recover better.
This study measures levels of beta-lactam antibiotics in the blood of ICU patients with sepsis to ensure the right dose is given. It aims to improve treatment by checking if antibiotic levels are effective without being too high or too low.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.